Literature DB >> 31103590

A Deep Learning Approach for Assessment of Regional Wall Motion Abnormality From Echocardiographic Images.

Kenya Kusunose1, Takashi Abe2, Akihiro Haga3, Daiju Fukuda4, Hirotsugu Yamada4, Masafumi Harada2, Masataka Sata4.   

Abstract

OBJECTIVES: This study investigated whether a deep convolutional neural network (DCNN) could provide improved detection of regional wall motion abnormalities (RWMAs) and differentiate among groups of coronary infarction territories from conventional 2-dimensional echocardiographic images compared with that of cardiologists, sonographers, and resident readers.
BACKGROUND: An effective intervention for reduction of misreading of RWMAs is needed. The hypothesis was that a DCNN trained using echocardiographic images would provide improved detection of RWMAs in the clinical setting.
METHODS: A total of 300 patients with a history of myocardial infarction were enrolled. From this cohort, 3 groups of 100 patients each had infarctions of the left anterior descending (LAD) artery, the left circumflex (LCX) branch, and the right coronary artery (RCA). A total of 100 age-matched control patients with normal wall motion were selected from a database. Each case contained cardiac ultrasonographs from short-axis views at end-diastolic, mid-systolic, and end-systolic phases. After the DCNN underwent 100 steps of training, diagnostic accuracies were calculated from the test set. Independently, 10 versions of the same model were trained, and ensemble predictions were performed using those versions.
RESULTS: For detection of the presence of WMAs, the area under the receiver-operating characteristic curve (AUC) produced by the deep learning algorithm was similar to that produced by the cardiologists and sonographer readers (0.99 vs. 0.98, respectively; p = 0.15) and significantly higher than the AUC result of the resident readers (0.99 vs. 0.90, respectively; p = 0.002). For detection of territories of WMAs, the AUC by the deep learning algorithm was similar to the AUC by the cardiologist and sonographer readers (0.97 vs. 0.95, respectively; p = 0.61) and significantly higher than the AUC by resident readers (0.97 vs. 0.83, respectively; p = 0.003). From a validation group at an independent site (n = 40), the AUC by the deep learning algorithm was 0.90.
CONCLUSIONS: The present results support the possibility of using DCNN for automated diagnosis of RWMAs in the field of echocardiography.
Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  artificial intelligence; diagnostic ability; echocardiography; regional wall motion abnormality

Year:  2019        PMID: 31103590     DOI: 10.1016/j.jcmg.2019.02.024

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN: 1876-7591


  26 in total

1.  Generalizable fully automated multi-label segmentation of four-chamber view echocardiograms based on deep convolutional adversarial networks.

Authors:  Arghavan Arafati; Daisuke Morisawa; Michael R Avendi; M Reza Amini; Ramin A Assadi; Hamid Jafarkhani; Arash Kheradvar
Journal:  J R Soc Interface       Date:  2020-08-19       Impact factor: 4.118

2.  Deep Learning for Detection of Exercise-Induced Pulmonary Hypertension Using Chest X-Ray Images.

Authors:  Kenya Kusunose; Yukina Hirata; Natsumi Yamaguchi; Yoshitaka Kosaka; Takumasa Tsuji; Jun'ichi Kotoku; Masataka Sata
Journal:  Front Cardiovasc Med       Date:  2022-06-15

3.  Validation of a deep-learning semantic segmentation approach to fully automate MRI-based left-ventricular deformation analysis in cardiotoxicity.

Authors:  Julia Karr; Michael Cohen; Samuel A McQuiston; Teja Poorsala; Christopher Malozzi
Journal:  Br J Radiol       Date:  2021-02-24       Impact factor: 3.039

4.  A deep-learning semantic segmentation approach to fully automated MRI-based left-ventricular deformation analysis in cardiotoxicity.

Authors:  By Julia Kar; Michael V Cohen; Samuel P McQuiston; Christopher M Malozzi
Journal:  Magn Reson Imaging       Date:  2021-02-08       Impact factor: 2.546

5.  Medical Professional Enhancement Using Explainable Artificial Intelligence in Fetal Cardiac Ultrasound Screening.

Authors:  Akira Sakai; Masaaki Komatsu; Reina Komatsu; Ryu Matsuoka; Suguru Yasutomi; Ai Dozen; Kanto Shozu; Tatsuya Arakaki; Hidenori Machino; Ken Asada; Syuzo Kaneko; Akihiko Sekizawa; Ryuji Hamamoto
Journal:  Biomedicines       Date:  2022-02-25

6.  Utility of a Deep-Learning Algorithm to Guide Novices to Acquire Echocardiograms for Limited Diagnostic Use.

Authors:  Akhil Narang; Richard Bae; Ha Hong; Yngvil Thomas; Samuel Surette; Charles Cadieu; Ali Chaudhry; Randolph P Martin; Patrick M McCarthy; David S Rubenson; Steven Goldstein; Stephen H Little; Roberto M Lang; Neil J Weissman; James D Thomas
Journal:  JAMA Cardiol       Date:  2021-06-01       Impact factor: 14.676

7.  Clinically Feasible and Accurate View Classification of Echocardiographic Images Using Deep Learning.

Authors:  Kenya Kusunose; Akihiro Haga; Mizuki Inoue; Daiju Fukuda; Hirotsugu Yamada; Masataka Sata
Journal:  Biomolecules       Date:  2020-04-25

Review 8.  Image-Based Cardiac Diagnosis With Machine Learning: A Review.

Authors:  Carlos Martin-Isla; Victor M Campello; Cristian Izquierdo; Zahra Raisi-Estabragh; Bettina Baeßler; Steffen E Petersen; Karim Lekadir
Journal:  Front Cardiovasc Med       Date:  2020-01-24

9.  Image Segmentation of the Ventricular Septum in Fetal Cardiac Ultrasound Videos Based on Deep Learning Using Time-Series Information.

Authors:  Ai Dozen; Masaaki Komatsu; Akira Sakai; Reina Komatsu; Kanto Shozu; Hidenori Machino; Suguru Yasutomi; Tatsuya Arakaki; Ken Asada; Syuzo Kaneko; Ryu Matsuoka; Daisuke Aoki; Akihiko Sekizawa; Ryuji Hamamoto
Journal:  Biomolecules       Date:  2020-11-08

10.  Deep learning to predict elevated pulmonary artery pressure in patients with suspected pulmonary hypertension using standard chest X ray.

Authors:  Kenya Kusunose; Yukina Hirata; Takumasa Tsuji; Jun'ichi Kotoku; Masataka Sata
Journal:  Sci Rep       Date:  2020-11-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.